Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Reply to Kalil et al., "Is Daptomycin plus Ceftaroline Associated with Better Clinical Outcomes than Standard of Care Monotherapy for Staphylococcus aureus Bacteremia?"

Sakoulas G, Geriak M, Haddad F, Rose W, LaPlante K, Zervos M, Kullar R, Nizet V.

Antimicrob Agents Chemother. 2019 Oct 22;63(11). pii: e01347-19. doi: 10.1128/AAC.01347-19. Print 2019 Nov. No abstract available.

PMID:
31640978
2.

Can the Perfect Handshake Hold the Key to Success and Sustainability of Antimicrobial Stewardship Programs?

Goff DA, Kullar R.

Clin Infect Dis. 2019 Oct 4. pii: ciz699. doi: 10.1093/cid/ciz699. [Epub ahead of print] No abstract available.

PMID:
31584636
3.

Antibiotics and adverse events: the role of antimicrobial stewardship programs in 'doing no harm'.

Bauer KA, Kullar R, Gilchrist M, File TM Jr.

Curr Opin Infect Dis. 2019 Dec;32(6):553-558. doi: 10.1097/QCO.0000000000000604.

PMID:
31567566
4.

Reply to Barner and Bruno-Murtha.

Kullar R, Nagel J, Bleasdale SC, Sutton SH, Naumovski S, Smith C, Leggett J, Wollins D, Busky C, Goldstein EJC.

Clin Infect Dis. 2019 Sep 23. pii: ciz935. doi: 10.1093/cid/ciz935. [Epub ahead of print] No abstract available.

PMID:
31544204
5.

Healthcare-associated urinary tract infections with onset post hospital discharge.

Elman MR, Williams CD, Bearden DT, Townes JM, Heintzman JD, Lapidus JA, Kullar R, Markwardt S, Trieu AT, Vahidi AA, McGregor JC.

Infect Control Hosp Epidemiol. 2019 Aug;40(8):863-871. doi: 10.1017/ice.2019.148. Epub 2019 Jun 20.

PMID:
31217038
6.

A Multidisciplinary Approach to Incorporate Bedside Nurses into Antimicrobial Stewardship and Infection Prevention.

Ha DR, Forte MB, Olans RD, OYong K, Olans RN, Gluckstein DP, Kullar R, Desai M, Catipon N, Ancheta V, Lira D, Khattak Y, Legge J, Nguyen KB, Chan S, Mourani J, McKinnell JA.

Jt Comm J Qual Patient Saf. 2019 Sep;45(9):600-605. doi: 10.1016/j.jcjq.2019.03.003. Epub 2019 Apr 25.

PMID:
31029590
7.

Clinical Data on Daptomycin plus Ceftaroline versus Standard of Care Monotherapy in the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia.

Geriak M, Haddad F, Rizvi K, Rose W, Kullar R, LaPlante K, Yu M, Vasina L, Ouellette K, Zervos M, Nizet V, Sakoulas G.

Antimicrob Agents Chemother. 2019 Apr 25;63(5). pii: e02483-18. doi: 10.1128/AAC.02483-18. Print 2019 May.

8.

Twitter to engage, educate, and advocate for global antibiotic stewardship and antimicrobial resistance.

Goff DA, Kullar R, Laxminarayan R, Mendelson M, Nathwani D, Osterholm M.

Lancet Infect Dis. 2019 Mar;19(3):229-231. doi: 10.1016/S1473-3099(19)30058-1. No abstract available.

PMID:
30833049
9.

Investigational drug therapies currently in early-stage clinical development for the treatment of clostridioides (clostridium) difficile infection.

Tran MN, Kullar R, Goldstein EJC.

Expert Opin Investig Drugs. 2019 Apr;28(4):323-335. doi: 10.1080/13543784.2019.1581763. Epub 2019 Feb 26. Review.

PMID:
30753786
10.

The association between perceived stigma and substance use disorder treatment outcomes: a review.

Crapanzano KA, Hammarlund R, Ahmad B, Hunsinger N, Kullar R.

Subst Abuse Rehabil. 2018 Dec 27;10:1-12. doi: 10.2147/SAR.S183252. eCollection 2019. Review.

11.

The More the Merrier? Should Antibiotics be Used for Rhinoplasty and Septorhinoplasty?-A Review.

Kullar R, Frisenda J, Nassif PS.

Plast Reconstr Surg Glob Open. 2018 Oct 16;6(10):e1972. doi: 10.1097/GOX.0000000000001972. eCollection 2018 Oct.

12.

Going for the Gold: A Description of the Centers of Excellence Designation by the Infectious Diseases Society of America.

Kullar R, Nagel J, Bleasdale SC, Sutton SH, Naumovski S, Rodriguez A, Smith C, Leggett J, Goldstein EJC.

Clin Infect Dis. 2019 May 2;68(10):1777-1782. doi: 10.1093/cid/ciy797.

PMID:
30239608
13.

A Roadmap to Implementing Antimicrobial Stewardship Principles in Long-term Care Facilities (LTCFs): Collaboration Between an Acute-Care Hospital and LTCFs.

Kullar R, Yang H, Grein J, Murthy R.

Clin Infect Dis. 2018 Apr 3;66(8):1304-1312. doi: 10.1093/cid/cix1041.

PMID:
29182743
14.

Reply to Bush and Kaye.

Kullar R, Goff DA, Bauer KA, File TM Jr.

Clin Infect Dis. 2017 Oct 16;65(9):1596. doi: 10.1093/cid/cix531. No abstract available.

PMID:
28591832
15.

Patients' Hand Washing and Reducing Hospital-Acquired Infection.

Haverstick S, Goodrich C, Freeman R, James S, Kullar R, Ahrens M.

Crit Care Nurse. 2017 Jun;37(3):e1-e8. doi: 10.4037/ccn2017694.

PMID:
28572111
16.

Eight Habits of Highly Effective Antimicrobial Stewardship Programs to Meet the Joint Commission Standards for Hospitals.

Goff DA, Kullar R, Bauer KA, File TM Jr.

Clin Infect Dis. 2017 Apr 15;64(8):1134-1139. doi: 10.1093/cid/cix065. Review.

PMID:
28203781
17.

PK/PD Target Attainment With Ceftolozane/Tazobactam Using Monte Carlo Simulation in Patients With Various Degrees of Renal Function, Including Augmented Renal Clearance and End-Stage Renal Disease.

Xiao AJ, Caro L, Popejoy MW, Huntington JA, Kullar R.

Infect Dis Ther. 2017 Mar;6(1):137-148. doi: 10.1007/s40121-016-0143-9. Epub 2016 Dec 24.

18.

Does moderate renal impairment affect clinical outcomes in complicated intra-abdominal and complicated urinary tract infections? Analysis of two randomized controlled trials with ceftolozane/tazobactam.

Kullar R, Wagenlehner FM, Popejoy MW, Long J, Yu B, Goldstein EJ.

J Antimicrob Chemother. 2017 Mar 1;72(3):900-905. doi: 10.1093/jac/dkw486.

PMID:
27999024
19.

A global call from five countries to collaborate in antibiotic stewardship: united we succeed, divided we might fail.

Goff DA, Kullar R, Goldstein EJC, Gilchrist M, Nathwani D, Cheng AC, Cairns KA, Escandón-Vargas K, Villegas MV, Brink A, van den Bergh D, Mendelson M.

Lancet Infect Dis. 2017 Feb;17(2):e56-e63. doi: 10.1016/S1473-3099(16)30386-3. Epub 2016 Nov 18. Review.

PMID:
27866945
20.

When sepsis persists: a review of MRSA bacteraemia salvage therapy.

Kullar R, Sakoulas G, Deresinski S, van Hal SJ.

J Antimicrob Chemother. 2016 Mar;71(3):576-86. doi: 10.1093/jac/dkv368. Epub 2015 Nov 12. Review.

PMID:
26565015
21.

Degowning the controversies of contact precautions for methicillin-resistant Staphylococcus aureus: A review.

Kullar R, Vassallo A, Turkel S, Chopra T, Kaye KS, Dhar S.

Am J Infect Control. 2016 Jan 1;44(1):97-103. doi: 10.1016/j.ajic.2015.08.003. Epub 2015 Sep 12. Review.

PMID:
26375351
22.

Acetabular paralabral cyst: an unusual cause of femoral vein compression.

Kullar RS, Kapron AL, Ihnat D, Aoki SK, Maak TG.

Arthrosc Tech. 2015 Jan 26;4(1):e35-40. doi: 10.1016/j.eats.2014.10.003. eCollection 2015 Feb.

23.

Association between vancomycin day 1 exposure profile and outcomes among patients with methicillin-resistant Staphylococcus aureus infective endocarditis.

Casapao AM, Lodise TP, Davis SL, Claeys KC, Kullar R, Levine DP, Rybak MJ.

Antimicrob Agents Chemother. 2015;59(6):2978-85. doi: 10.1128/AAC.03970-14. Epub 2015 Mar 9.

24.

Review of Twitter for infectious diseases clinicians: useful or a waste of time?

Goff DA, Kullar R, Newland JG.

Clin Infect Dis. 2015 May 15;60(10):1533-40. doi: 10.1093/cid/civ071. Epub 2015 Feb 4.

PMID:
25652087
25.

Examining the use of ceftaroline in the treatment of Streptococcus pneumoniae meningitis with reference to human cathelicidin LL-37.

Sakoulas G, Nonejuie P, Kullar R, Pogliano J, Rybak MJ, Nizet V.

Antimicrob Agents Chemother. 2015 Apr;59(4):2428-31. doi: 10.1128/AAC.04965-14. Epub 2015 Jan 20.

26.

MPFL reconstruction: technique and results.

Reagan J, Kullar R, Burks R.

Orthop Clin North Am. 2015 Jan;46(1):159-69. doi: 10.1016/j.ocl.2014.09.012. Review.

PMID:
25435045
27.

Reply to Eschenauer et al.

Kullar R, McKinnell JA, Sakoulas G.

Clin Infect Dis. 2015 Feb 15;60(4):671-2. doi: 10.1093/cid/ciu885. Epub 2014 Nov 3. No abstract available.

28.

Suture placement near the musculotendinous junction in the supraspinatus: implications for rotator cuff repair.

Kullar RS, Reagan JM, Kolz CW, Burks RT, Henninger HB.

Am J Sports Med. 2015 Jan;43(1):57-62. doi: 10.1177/0363546514553091. Epub 2014 Oct 23.

PMID:
25342649
29.

Use of electronic health records and clinical decision support systems for antimicrobial stewardship.

Forrest GN, Van Schooneveld TC, Kullar R, Schulz LT, Duong P, Postelnick M.

Clin Infect Dis. 2014 Oct 15;59 Suppl 3:S122-33. doi: 10.1093/cid/ciu565.

PMID:
25261539
30.

A pilot study of the efficacy and safety of empiric daptomycin therapy in oncology patients with fever and severe neutropenia.

Bubalo JS, Kullar R, Maziarz RT.

Ther Adv Infect Dis. 2013 Dec;1(6):183-90. doi: 10.1177/2049936113504090.

32.

Antimicrobial salvage therapy for persistent staphylococcal bacteremia using daptomycin plus ceftaroline.

Sakoulas G, Moise PA, Casapao AM, Nonejuie P, Olson J, Okumura CY, Rybak MJ, Kullar R, Dhand A, Rose WE, Goff DA, Bressler AM, Lee Y, Pogliano J, Johns S, Kaatz GW, Ebright JR, Nizet V.

Clin Ther. 2014 Oct 1;36(10):1317-33. doi: 10.1016/j.clinthera.2014.05.061. Epub 2014 Jul 10.

PMID:
25017183
33.

MPFL reconstruction: technique and results.

Reagan J, Kullar R, Burks R.

Clin Sports Med. 2014 Jul;33(3):501-16. doi: 10.1016/j.csm.2014.03.006. Epub 2014 May 20. Review.

PMID:
24993412
34.

Evaluation of vancomycin population susceptibility analysis profile as a predictor of outcomes for patients with infective endocarditis due to methicillin-resistant Staphylococcus aureus.

Casapao AM, Davis SL, McRoberts JP, Lagnf AM, Patel S, Kullar R, Levine DP, Rybak MJ.

Antimicrob Agents Chemother. 2014 Aug;58(8):4636-41. doi: 10.1128/AAC.02820-13. Epub 2014 Jun 2.

35.

Transformation of antimicrobial stewardship programs through technology and informatics.

Kullar R, Goff DA.

Infect Dis Clin North Am. 2014 Jun;28(2):291-300. doi: 10.1016/j.idc.2014.01.009. Epub 2014 Apr 5. Review.

PMID:
24857394
36.

Efficacy and safety of daptomycin in patients with renal impairment: a multicenter retrospective analysis.

Kullar R, McClellan I, Geriak M, Sakoulas G.

Pharmacotherapy. 2014 Jun;34(6):582-9. doi: 10.1002/phar.1413. Epub 2014 Mar 21.

PMID:
24658897
37.

A multicentre evaluation of the effectiveness and safety of high-dose daptomycin for the treatment of infective endocarditis.

Kullar R, Casapao AM, Davis SL, Levine DP, Zhao JJ, Crank CW, Segreti J, Sakoulas G, Cosgrove SE, Rybak MJ.

J Antimicrob Chemother. 2013 Dec;68(12):2921-6. doi: 10.1093/jac/dkt294. Epub 2013 Aug 8.

38.

Multicenter study of high-dose daptomycin for treatment of enterococcal infections.

Casapao AM, Kullar R, Davis SL, Levine DP, Zhao JJ, Potoski BA, Goff DA, Crank CW, Segreti J, Sakoulas G, Cosgrove SE, Rybak MJ.

Antimicrob Agents Chemother. 2013 Sep;57(9):4190-6. doi: 10.1128/AAC.00526-13. Epub 2013 Jun 17.

39.

The "epic" challenge of optimizing antimicrobial stewardship: the role of electronic medical records and technology.

Kullar R, Goff DA, Schulz LT, Fox BC, Rose WE.

Clin Infect Dis. 2013 Oct;57(7):1005-13. doi: 10.1093/cid/cit318. Epub 2013 May 10.

PMID:
23667260
40.

Use of electronic health record data to identify skin and soft tissue infections in primary care settings: a validation study.

Levine PJ, Elman MR, Kullar R, Townes JM, Bearden DT, Vilches-Tran R, McClellan I, McGregor JC.

BMC Infect Dis. 2013 Apr 10;13:171. doi: 10.1186/1471-2334-13-171.

41.

Comparative epidemiology of bacteremia due to methicillin-resistant Staphylococcus aureus between older and younger adults: a propensity score analysis.

Kullar R, Rybak MJ, Kaye KS.

Infect Control Hosp Epidemiol. 2013 Apr;34(4):400-6. doi: 10.1086/669868. Epub 2013 Feb 15.

PMID:
23466914
42.

Early use of daptomycin versus vancomycin for methicillin-resistant Staphylococcus aureus bacteremia with vancomycin minimum inhibitory concentration >1 mg/L: a matched cohort study.

Murray KP, Zhao JJ, Davis SL, Kullar R, Kaye KS, Lephart P, Rybak MJ.

Clin Infect Dis. 2013 Jun;56(11):1562-9. doi: 10.1093/cid/cit112. Epub 2013 Feb 28.

PMID:
23449272
43.

Implementation of an antimicrobial stewardship pathway with daptomycin for optimal treatment of methicillin-resistant Staphylococcus aureus bacteremia.

Kullar R, Davis SL, Kaye KS, Levine DP, Pogue JM, Rybak MJ.

Pharmacotherapy. 2013 Jan;33(1):3-10. doi: 10.1002/phar.1220.

PMID:
23307539
44.

The effect of delay time between primary melanoma biopsy and sentinel lymph node dissection on sentinel node status, recurrence, and survival.

Parrett BM, Accortt NA, Li R, Dosanjh AS, Thummala S, Kullar R, Cleaver JE, Kashani-Sabet M, Leong SP.

Melanoma Res. 2012 Oct;22(5):386-91. doi: 10.1097/CMR.0b013e32835861f6.

PMID:
22955010
45.

Effects of targeting higher vancomycin trough levels on clinical outcomes and costs in a matched patient cohort.

Kullar R, Davis SL, Taylor TN, Kaye KS, Rybak MJ.

Pharmacotherapy. 2012 Mar;32(3):195-201. doi: 10.1002/j.1875-9114.2011.01017.x. Erratum in: Pharmacotherapy. 2012 Sep;32(9):869.

PMID:
22392452
46.

High-dose daptomycin for treatment of complicated gram-positive infections: a large, multicenter, retrospective study.

Kullar R, Davis SL, Levine DP, Zhao JJ, Crank CW, Segreti J, Sakoulas G, Cosgrove SE, Rybak MJ.

Pharmacotherapy. 2011 Jun;31(6):527-36. doi: 10.1592/phco.31.6.527.

PMID:
21923436
47.

Validation of the effectiveness of a vancomycin nomogram in achieving target trough concentrations of 15-20 mg/L suggested by the vancomycin consensus guidelines.

Kullar R, Leonard SN, Davis SL, Delgado G Jr, Pogue JM, Wahby KA, Falcione B, Rybak MJ.

Pharmacotherapy. 2011 May;31(5):441-8. doi: 10.1592/phco.31.5.441.

PMID:
21923425
48.

Pharmacokinetics of single-dose daptomycin in patients with suspected or confirmed neurological infections.

Kullar R, Chin JN, Edwards DJ, Parker D, Coplin WM, Rybak MJ.

Antimicrob Agents Chemother. 2011 Jul;55(7):3505-9. doi: 10.1128/AAC.01741-10. Epub 2011 Apr 18.

49.

Impact of vancomycin exposure on outcomes in patients with methicillin-resistant Staphylococcus aureus bacteremia: support for consensus guidelines suggested targets.

Kullar R, Davis SL, Levine DP, Rybak MJ.

Clin Infect Dis. 2011 Apr 15;52(8):975-81. doi: 10.1093/cid/cir124.

PMID:
21460309
50.

Microwave exposure increases bone demineralization rate independent of temperature.

Tinling SP, Giberson RT, Kullar RS.

J Microsc. 2004 Sep;215(Pt 3):230-5.

Supplemental Content

Loading ...
Support Center